Affiliations 

  • 1 Institute of New Drug Development, China Medical University, Taichung, Taiwan
  • 2 Regenerative Medicine Cluster, Advanced Medical and Dental Institute (AMDI) Universiti Sains Malaysia, Penang, Malaysia
  • 3 Department of Biotechnology, China Medical University, Taichung, Taiwan
  • 4 Institute of New Drug Development, China Medical University, Taichung, Taiwan. yitlung.khung@mail.cmu.edu.tw
Sci Rep, 2017 04 11;7(1):793.
PMID: 28400564 DOI: 10.1038/s41598-017-00912-3

Abstract

Measuring at ~30 nm, a fully customizable holliday junction DNA nanoconstruct, was designed to simultaneously carry three unmodified SiRNA strands for apoptosis gene knockout in cancer cells without any assistance from commercial transfection kits. In brief, a holliday junction structure was intelligently designed to present one arm with a cell targeting aptamer (AS1411) while the remaining three arms to carry different SiRNA strands by means of DNA/RNA duplex for inducing apoptosis in cancer cells. By carrying the three SiRNA strands (AKT, MDM2 and Survivin) into triple negative breast MDA-MB-231 cancer cells, cell number had reduced by up to ~82% within 24 hours solely from one single administration of 32 picomoles. In the immunoblotting studies, up-elevation of phosphorylated p53 was observed for more than 8 hours while the three genes of interest were suppressed by nearly half by the 4-hour mark upon administration. Furthermore, we were able to demonstrate high cell selectivity of the nanoconstruct and did not exhibit usual morphological stress induced from liposomal-based transfection agents. To the best of the authors' knowledge, this system represents the first of its kind in current literature utilizing a short and highly customizable holliday DNA junction to carry SiRNA for apoptosis studies.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.